mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.006 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.006 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.007 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.008 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.009 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.009 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |